ASH Selects Seven Fellows to Receive Research Training Award to Support Careers in Academic Hematology
(WASHINGTON, June 30, 2016) The American Society of Hematology (ASH) today announced the names of seven outstanding fellows selected to receive the 2016 ASH Research Training Award for Fellows (RTAF), a year-long program that aims to encourage careers in academic hematology by providing protected research time during training.
Each RTAF awardee will receive $55,000 to support a hematology research project throughout the program’s duration, from July 1, 2016, to June 30, 2017. The majority of the award money will support the recipient’s salary, with a percentage to be used for research supplies and ASH annual meeting attendance. Awards are targeted to two groups of researchers based on experience: a Junior Investigator award for second- and third-year fellows, and a Senior Investigator award for fourth- and fifth-year fellows.
“Fellows who conduct high-quality research during their training improve their chances of receiving an academic appointment and research funding to start their careers; however, it is often difficult to devote time to research,” said ASH President Charles S. Abrams, MD, of University of Pennsylvania. “By supporting protected time for scientific exploration, the RTAF award positions the next generation of physician-scientists for successful careers in hematology.”
The 2016 ASH Research Training Award for Fellow recipients and their research topics are:
| Recipient | Research Topics |
|
Waitmann Aumann, MD |
CRM1 dimerization: A novel mechanism in CALM-AF10leukemia |
|
Shruti Chaturvedi, MBBS |
Alternate pathway of complement in adults with sickle cell disease and acute chest syndrome |
|
Gordon Cohen, MD, MPH |
Overcoming imatinib resistance in pediatric Philadelphia chromosome-positive acute lymphocytic leukemia |
|
Anna Halpern, MD |
Developing and testing models to predict intensive care unit (ICU) admission and mortality for adults with acute myeloid leukemia (AML) |
|
Sakiko Suzuki, MD |
Novel therapy of leukemia through alternative splicing of MPL |
|
Justin Taylor, MD |
Biological and mechanistic effects of XPO1alterations in hematopoietic malignancies |
|
Amy Tang, MD |
Transfusion-related iron overload and post-transplantation outcomes in a chemotherapy-based mouse model of allogeneic stem cell transplant |
The American Society of Hematology (www.hematology.org) is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.
CONTACT:
Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission